Nickel titanium

Global Guidewires (Nitinol, Stainless Steel, Others) Market Report 2024: Analysis & Forecasts 2019-2022 and 2023-2029 - Minimally Invasive Techniques Expand, Boosting Guidewire Utilization - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 12, 2024
General Health, Health, Medical Supplies, Medical Devices, Disease, PVI, Friction, ERCP, Coronary artery disease, Conditional sentence, Bacteria, Epidemiology, Specialization, Risk, Investment, Infection, Patient safety, USD, Surgery, Non-communicable disease, Cardiovascular disease, Fungal infection, Obesity, Biotechnology, Peripheral artery disease, Porter's five forces analysis, Diabetes, Chlorhexidine, World Health Organization, Safety, Fatigue, Hypertension, Cardiology, Neurology, Urology, Prevalence, Death, PCI, Diagnosis, Arrhythmia, Temperature, Growth, Incidence, Anatomy, SWOT, Mortality, Stainless steel, WHO, Nickel titanium, Physician, Medical imaging

Guidewires Market is being propelled increasing prevalence of cardiovascular diseases, technological advancements in guidewire design and materials, rising demand for minimally invasive procedures, and expanding healthcare infrastructure in developing economies.

Key Points: 
  • Guidewires Market is being propelled increasing prevalence of cardiovascular diseases, technological advancements in guidewire design and materials, rising demand for minimally invasive procedures, and expanding healthcare infrastructure in developing economies.
  • As the prevalence of risk factors such as obesity, diabetes, and hypertension increase, so does the incidence of cardiovascular diseases.
  • Guidewires are essential tools in percutaneous coronary interventions (PCI), peripheral vascular interventions (PVI), and electrophysiology procedures, driving the demand for guidewires.
  • The increasing prevalence of chronic diseases worldwide drives the demand for guidewires by necessitating minimally invasive interventions for diagnosis and treatment.

Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System™ in Patients

Retrieved on: 
Wednesday, February 7, 2024
Cardiology, Physician, Food and Drug Administration, Aspiration, Patient, UCLA, FDA, Nickel titanium, Food, System, Interventional radiology, Coronary thrombosis

IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Innova Vascular, Inc. today announced successful early commercial use of the company's Laguna Thrombectomy System™.

Key Points: 
  • IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Innova Vascular, Inc. today announced successful early commercial use of the company's Laguna Thrombectomy System™.
  • The Laguna Thrombectomy System encompasses two devices developed by Innova Vascular: the Malibu Aspiration Catheter™ System and the Laguna Clot Retriever™ System.
  • "We are extremely pleased with the early clinical performance of the system and look forward to expanding our product launch in the period ahead," said Sanjay Shrivastava, Ph.D., CEO of Innova Vascular.
  • "Successful use of the System marks an important milestone in our commitment to develop innovative technologies targeting large, underserved markets.

Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency

Retrieved on: 
Wednesday, November 8, 2023
Software, Data Management, Technology, Medical Devices, Other Manufacturing, Artificial Intelligence, Health Technology, Textiles, Engineering, Transport, Health, Logistics, Supply Chain Management, Manufacturing, Science, Memory, Super Elastic Bubble Plastic, Partnership, CPG, Medical device, Nickel titanium, Genpact

Confluent Medical, a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), has experienced significant improvements to its end-to-end supply chain with Kinaxis.

Key Points: 
  • Confluent Medical, a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), has experienced significant improvements to its end-to-end supply chain with Kinaxis.
  • The medical technology (medtech) innovator, that delivers life-saving implants, minimally invasive delivery systems and other medical devices, deployed Kinaxis® in August 2023 with the help of Genpact and credits increased visibility and efficiency to the partnership.
  • Jeff McCoun, vice president, global supply chain at Confluent Medical said, “We had a demand peak that nearly doubled and normally it would have taken months to re-sync our supply chain, but we did it in just weeks.
  • Its AI-powered technology and patented concurrency technique allows companies to orchestrate their supply chain network end-to-end from strategic planning to last-mile delivery.

BioCircuit Technologies Receives $2.4 Million NIH Award

Retrieved on: 
Thursday, October 19, 2023
FDA, Small business, Small Business Innovation Research, NINDS, Chronic pain, SBIR, Commercial, NIH, DSM-IV codes, Virginia Commonwealth University, CRP, Patient, Bangladesh Technical Education Board, Pharmaceutical industry, Nickel titanium, Stroke

Atlanta, GA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- BioCircuit Technologies , an Atlanta-based medical device company, has received from the National Institutes of Health (NIH) a $1.9 million grant with the intent to fund $2.4 million over three years.

Key Points: 
  • Atlanta, GA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- BioCircuit Technologies , an Atlanta-based medical device company, has received from the National Institutes of Health (NIH) a $1.9 million grant with the intent to fund $2.4 million over three years.
  • The award will be used to complete development and commercial launch of Nerve Tape®, the first device for sutureless repair of transected nerves.
  • Each year, an estimated 1.4 million patients in the U.S. suffer traumatic peripheral nerve injury, often resulting in irreversible loss of function and chronic pain.
  • Led by the BioCircuit team, the newly funded project will clear remaining regulatory and production hurdles and achieve market readiness for initial commercial launch.

Dr. Ming H. Wu, Former Senior Vice President of Engineering at Edwards Lifesciences, Joins Medeologix as Board Member and Advisor

Retrieved on: 
Monday, October 9, 2023
Senior, Knowledge, Biology, Engineering, American Institute for Medical and Biological Engineering, Materials Science and Engineering B, Biomedical engineering, Medicine, UCLA, Champaign–Urbana metropolitan area, University, Aluminium alloy, Doctor of Philosophy, AIMBE, Fairfield University, Journal, Materials science, ASTM, ASM, Material, Publication, Biomedicine, Science, Memory, Edwards Lifesciences, Face, Research, Medical device, Pseudoelasticity, Nickel titanium

Throughout his illustrious career at Edwards Lifesciences, he played a pivotal role in advancing cutting-edge technologies in heart valve design, testing and manufacturing.

Key Points: 
  • Throughout his illustrious career at Edwards Lifesciences, he played a pivotal role in advancing cutting-edge technologies in heart valve design, testing and manufacturing.
  • A reliable partner like Medeologix, with its efficient one-stop approach and expertise in design for manufacturability and scaled-up manufacturing, is device industry's ideal collaborator.
  • With Dr. Wu's joining as a board member and advisor, Medeologix is able to further enhance its technology capability and industry networking, and demonstrate its dedication to serving customers' needs.
  • His affiliation and involvement in Shape Memory and Superelasticity (SMST) has helped shape the field of materials science and engineering for medical device applications.

Resonetics Completes Acquisition of Memry and SAES Smart Materials

Retrieved on: 
Monday, October 2, 2023
Workforce, SAES Getters, Elective surgery, Material, Titanium, Acquisition, Nickel, Electrophysiology, Nickel titanium, Growth, 3D printing, Resonet in laudibus, Memory

NASHUA, N.H., Oct. 2, 2023 /PRNewswire/ -- Resonetics announced today that it has completed the previously announced acquisition of Memry Corporation and SAES Smart Materials, Inc. from SAES Getters S.p.A., Milan, Italy. Memry Corporation and Smart Materials are recognized leaders in the nitinol supply chain for the medical device industry with operations in Bethel, Connecticut, New Hartford, New York, and Menlo Park, California. Both companies will be rebranded as Resonetics.

Key Points: 
  • Advances nitinol material and processing capabilities, providing medical device customers with a comprehensive suite of solutions
    NASHUA, N.H., Oct. 2, 2023 /PRNewswire/ -- Resonetics announced today that it has completed the previously announced acquisition of Memry Corporation and SAES Smart Materials, Inc. from SAES Getters S.p.A., Milan, Italy.
  • Memry Corporation and Smart Materials are recognized leaders in the nitinol supply chain for the medical device industry with operations in Bethel, Connecticut, New Hartford, New York, and Menlo Park, California.
  • "Memry and SAES Smart Materials have built a legacy as critical suppliers of nitinol mill products, semi-finished materials, and complex components and implants to the medical device industry," said Kevin Kelly, President and CEO of Resonetics.
  • "The addition of Memry and SAES Smart Materials adds important nitinol material knowledge and proficiency in melt to component manufacturing.

Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever™ System and Malibu Aspiration Catheter™ System

Retrieved on: 
Wednesday, June 7, 2023
Innova, UCLA School of Dentistry, Food and Drug Administration, David Geffen School of Medicine at UCLA, Blood, Thrombectomy, Patient, Malibu, Thrombus, Nickel titanium, System, Aspiration, FDA, Massachusetts General Hospital, Embolism, Food, Medical imaging, Medicine

The two new devices are collectively known as the Laguna Thrombectomy System.

Key Points: 
  • The two new devices are collectively known as the Laguna Thrombectomy System.
  • The Malibu Aspiration Catheter System offers excellent navigability and ease of use, with the ability for operators of all skill levels to remove clots efficiently.
  • "The Laguna Thrombectomy System offers an innovative solution to treat a wide range of clots in the peripheral vasculature."
  • The System offers a comprehensive range of sizes of the Malibu Aspiration Catheter as well as the Laguna Clot Retriever.

Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis Report By Implantation Procedure, By Material, By Mechanism, By End-Use, By Region And Segment Forecasts, 2023 - 2030

Retrieved on: 
Tuesday, March 14, 2023
Aortic stenosis, AR, Ageing, Cardiovascular disease, Patient, Stenosis, Heart, Prevalence, TAVR, American College, AS, Risk, Hospital, Growth, Nickel titanium, Woman, Cardiology, Implantation, USD, Rheumatic fever, Medical device, Pharmaceutical industry

NEW YORK, March 14, 2023 /PRNewswire/ -- Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis Report By Implantation Procedure (Transfemoral, Transapical, Transaortic), By Material, By Mechanism, By End-Use, By Region, And Segment Forecasts, 2023 - 2030

Key Points: 
  • NEW YORK, March 14, 2023 /PRNewswire/ -- Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis Report By Implantation Procedure (Transfemoral, Transapical, Transaortic), By Material, By Mechanism, By End-Use, By Region, And Segment Forecasts, 2023 - 2030
    The global transcatheter aortic valve replacement market size is expected to reach USD 10.2 billion by 2030, expanding at 7.2% CAGR from 2023 to 2030.
  • The rising geriatric population and the prevalence of risk factors like aortic valve stenosis (AS) and other diseases continue to drive the demand for transcatheter aortic valve replacement (TAVR) procedures.
  • According to the World Heart Federation 2022, rheumatic heart disease affected 39 million individuals globally.
  • Based on the implantation procedure, the transfemoral segment held the largest market share of 53.6% in terms of revenue in 2022.

Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023

Retrieved on: 
Wednesday, February 8, 2023
American College, ENOV, Booth, NYSE, American College of Foot and Ankle Surgeons, ACFAS, Convention, Conference, PST, Exhibition Hall of the Ministry of Culture, Renewable energy, Sports equipment, Nightclub, Ankle, Nickel titanium, Foot

Wilmington, DE, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase its growing Foot & Ankle offerings at the 2023 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Los Angeles from February 9-12, 2023.

Key Points: 
  • Wilmington, DE, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase its growing Foot & Ankle offerings at the 2023 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Los Angeles from February 9-12, 2023.
  • “Last year, we introduced ourselves to the podiatric community at ACFAS as a new player in the market, building a strong foundation while bringing together multiple product portfolios,” said Gary Justak, President and General Manager of Enovis Foot & Ankle.
  • “This year, we are energized to once again have a presence at ACFAS and showcase our growing portfolio of cutting-edge solutions, designed to improve both efficiency and outcomes for our customers and their patients.”
    Enovis will highlight products from its expanding foot and ankle portfolio, including:
    DynaNail Helix™ , which provides sustained, dynamic compression with disruptive NiTiNOL technology.
  • Arsenal Ankle Plating System™ , a comprehensive ankle plating portfolio that expands offerings to address both tri-malleolar and intra-articular fracture patterns.

Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples

Retrieved on: 
Tuesday, January 17, 2023
Ankle, MTP, Foot, ENOV, MD, NYSE, Patient, MBA, Delta, Quattro, Nickel titanium

Designed to give foot and ankle surgeons ease of use and procedural efficiency in the operating room, the DynaClip Delta™ and DynaClip Quattro™ staples are pre-loaded on disposable inserters that facilitate quick deployment and accurate leg positioning.

Key Points: 
  • Designed to give foot and ankle surgeons ease of use and procedural efficiency in the operating room, the DynaClip Delta™ and DynaClip Quattro™ staples are pre-loaded on disposable inserters that facilitate quick deployment and accurate leg positioning.
  • In addition, the DynaClip Delta staples are designed to deliver faster and easier first metatarsophalangeal (MTP) fusion procedures without compromising on durability and performance.
  • The DynaClip Quattro NiTiNOL staple is a newly designed four-legged staple advancing the current design of NiTiNOL staples on the market,” said Tyler Gonzalez, MD, MBA, a Foot & Ankle Surgeon in Lexington, South Carolina.
  • Unlike traditional NiTiNOL staples that provide bone compression through the staple legs, DynaClip Delta and DynaClip Quattro staples are designed to distribute stress across the staple bridge.